Purchases and Sales Made in Q2 2024 in Enlivex Therapeutics Ltd. (ENLV)
This table provides information about the institutional ownership of Enlivex Therapeutics Ltd. (ENLV) during Q2 2024. The information is specifically focused on institutions that hold shares of Enlivex Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
1.7MNew |
$2.16M - $7.33M
|
1.7M
$1.85M
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
173K+ 239.56% |
$219K - $745K
|
245K
$267K
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
173K+ 239.56% |
$219K - $745K
|
245K
$267K
|
|
|
Aug 12, 2024
Q2 2024
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
24.8KNew |
$31.5K - $107K
|
24.8K
$27.1K
|
|
|
Aug 13, 2024
Q2 2024
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
11.4KNew |
$14.5K - $49.3K
|
11.4K
$12.5K
|
|
|
Aug 09, 2024
Q2 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
1.8K+ 2.58% |
$2.29K - $7.76K
|
71.7K
$78.1K
|
|
|
Jul 30, 2024
Q2 2024
|
Activest Wealth Management
|
BUY
|
- |
1KNew |
$1.27K - $4.31K
|
1K
$1.09K
|
|
|
Aug 06, 2024
Q2 2024
|
Srs Capital Advisors, Inc.
Denver, CO |
BUY
|
- |
615New |
$781 - $2.65K
|
615
$670
|
|
|
Jul 23, 2024
Q2 2024
|
Global Retirement Partners, LLC
|
BUY
|
- |
11New |
$14 - $47.4
|
11
$12
|
|
|
Jul 23, 2024
Q2 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 13, 2024
Q2 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-809- 8.1% |
$1.03K - $3.49K
|
9.18K
$10K
|
|
|
Aug 14, 2024
Q2 2024
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-1.48K- 20.42% |
$1.87K - $6.36K
|
5.75K
$6.27K
|
|
|
Dec 26, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.58K- 87.27% |
$2.01K - $6.82K
|
231
$252
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-3.05K- 99.48% |
$3.88K - $13.2K
|
16
$17.4
|
|
|
Aug 12, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-6.92K- 96.77% |
$8.79K - $29.8K
|
231
$252
|